Kevin Yeaman - Oct 25, 2024 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
Stock symbol
DLB
Transactions as of
Oct 25, 2024
Transactions value $
-$1,051,925
Form type
4
Date filed
11/27/2024, 05:44 PM
Previous filing
Nov 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $3.12M +50K +59.72% $62.32 134K Nov 25, 2024 By a trust F1
transaction DLB Class A Common Stock Sale -$3.95M -49.1K -36.72% $80.53 84.6K Nov 25, 2024 By a trust F1, F2
transaction DLB Class A Common Stock Sale -$72.7K -896 -1.06% $81.18 83.7K Nov 25, 2024 By a trust F1, F3
transaction DLB Class A Common Stock Options Exercise $492K +7.89K +9.42% $62.32 91.6K Nov 26, 2024 By a trust F1
transaction DLB Class A Common Stock Sale -$633K -7.89K -8.61% $80.19 83.7K Nov 26, 2024 By a trust F1
holding DLB Class A Common Stock 120K Oct 25, 2024 Direct F4
holding DLB Class A Common Stock 2.56 Oct 25, 2024 By a son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -50K -86.37% $0.00 7.89K Nov 25, 2024 Class A Common Stock 50K $62.32 By a trust F1, F5
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -7.89K -100% $0.00 0 Nov 26, 2024 Class A Common Stock 7.89K $62.32 By a trust F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
F2 The shares were sold in multiple transactions at prices ranging from $80.125 to $81.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 The shares were sold in multiple transactions at prices ranging from $81.135 to $81.215, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 Shares held following the reported transactions include 120,320 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F5 This performance-based stock option award was granted for a total of 90,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 86,400 shares.